Literature DB >> 29100915

Dynamic status of metabolically healthy overweight/obesity and metabolically unhealthy and normal weight and the risk of type 2 diabetes mellitus: A cohort study of a rural adult Chinese population.

Bingyuan Wang1, Ming Zhang2, Shu Wang2, Chongjian Wang1, Jinjin Wang3, Linlin Li1, Lu Zhang1, Yongcheng Ren4, Chengyi Han4, Yang Zhao4, Junmei Zhou5, Guo'an Wang6, Yanxia Shen7, Dongting Wu7, Chao Pang8, Lei Yin8, Tianping Feng8, Jingzhi Zhao8, Xinping Luo2, Dongsheng Hu9.   

Abstract

OBJECTIVE: We aimed to determine dynamic status of metabolically healthy overweight or obesity (MHO) and metabolically unhealthy and normal weight (MUNW) and the risk of incident type 2 diabetes mellitus (T2DM).
METHODS: Body mass index and metabolic health were assessed on 11,865 eligible participants ≥18 years from 6-year follow-up cohort study of a rural Chinese population. Participants were classified as metabolically healthy and normal weight (MHNW), MHO, MUNW and metabolically unhealthy overweight or obesity (MUO) at both baseline and follow-up examinations. Hazard ratio (HR) and 95% confidence interval (CI) were used to assess baseline and their changes of BMI-metabolic status and the risk of incident T2DM.
RESULTS: Risk of T2DM was increased for all participants with baseline MHO, MUNW, and MUO (adjusted HR 1.94, 95% CI 1.33-2.81; 3.10, 95% CI 2.19-4.39; and 6.63, 95% CI 4.94-8.90, all P<0.001, respectively). However, risk of T2DM was increased for participants with transformation from MHO to MUO (4.52, 95% CI 2.42-8.47, P<0.001) as compared with stable MHNW, but not stable MHO (0.53, 95CI 0.20-1.40, P=0.20). Risk of T2DM did not differ between participants with transformation from MUNW to metabolically healthy and those with stable MHNW (P>0.05), but was increased with stable MUNW (5.78, 95% CI 3.15-10.62, P<0.001). The results were consistent when analyses were restricted to participants without baseline impaired fasting glucose level.
CONCLUSIONS: Our findings provide understanding for differentiating high-risk individuals for incident T2DM in Chinese population.
Copyright © 2017 Asia Oceania Association for the Study of Obesity. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cohort study; Diabetes mellitus; Epidemiology; Metabolic diseases; Obesity

Mesh:

Year:  2017        PMID: 29100915     DOI: 10.1016/j.orcp.2017.10.005

Source DB:  PubMed          Journal:  Obes Res Clin Pract        ISSN: 1871-403X            Impact factor:   2.288


  11 in total

1.  Relationships Between Metabolic Body Composition Status and Rapid Kidney Function Decline in a Community-Based Population: A Prospective Observational Study.

Authors:  Shao-Chi Chu; Po-Hsi Wang; Kuan-Ying Lu; Chia-Chun Ko; Yun-Hsuan She; Chin-Chan Lee; I-Wen Wu; Chiao-Yin Sun; Heng-Jung Hsu; Heng-Chih Pan
Journal:  Front Public Health       Date:  2022-06-03

Review 2.  Association of weight status and the risks of diabetes in adults: a systematic review and meta-analysis of prospective cohort studies.

Authors:  Hong-Jie Yu; Mandy Ho; Xiangxiang Liu; Jundi Yang; Pui Hing Chau; Daniel Yee Tak Fong
Journal:  Int J Obes (Lond)       Date:  2022-02-23       Impact factor: 5.551

Review 3.  Metabolically healthy obesity: facts and fantasies.

Authors:  Gordon I Smith; Bettina Mittendorfer; Samuel Klein
Journal:  J Clin Invest       Date:  2019-10-01       Impact factor: 14.808

4.  Association of Metabolic Obesity Phenotypes and Total Testosterone in Chinese Male Population.

Authors:  Luna Liu; Shuang Liu; Qianmei Song; Dandan Luo; Yu Su; Xiangyu Qi; Qian Wang; Jing Ning; Youyuan Lv; Qingbo Guan
Journal:  Diabetes Metab Syndr Obes       Date:  2021-01-29       Impact factor: 3.168

5.  Effect of Metabolic Health and Obesity Phenotype on Risk of Diabetes Mellitus: A Population-Based Longitudinal Study.

Authors:  Xiaoyue Zhu; Jingyao Hu; Haijian Guo; Dakang Ji; Defu Yuan; Mingma Li; Tao Yan; Chenghao Xue; Haonan Ma; Xu Zhou; Yuxiang Liu; You Li; Kaicheng Sun; Yu Liu; Zilin Sun; Bei Wang
Journal:  Diabetes Metab Syndr Obes       Date:  2021-08-05       Impact factor: 3.168

6.  Cost-Effectiveness of Conbercept vs. Ranibizumab for Age-Related Macular Degeneration, Diabetic Macular Edema, and Pathological Myopia: Population-Based Cohort Study and Markov Model.

Authors:  Zhuang Cui; Wei Zhou; Qinxue Chang; Tiantian Zhang; Hui Wang; Xiangda Meng; Yuanyuan Liu; Hua Yan
Journal:  Front Med (Lausanne)       Date:  2021-12-02

Review 7.  Metabolically healthy obesity: Is it really healthy for type 2 diabetes mellitus?

Authors:  Qi Wu; Ming-Feng Xia; Xin Gao
Journal:  World J Diabetes       Date:  2022-02-15

8.  Short-Term Changes in Metabolically Healthy Overweight/Obesity Status Impact the Susceptibility to Type 2 Diabetes in Chinese Adults.

Authors:  Jie Min; Xiang Hu; Jiaoyue Zhang; Tianshu Zeng; Ying Wang; Shenghua Tian; Geng Liu; Xueyu Zhong; Kangli Qiu; Miaomiao Peng; Lulu Chen
Journal:  Diabetes Metab Syndr Obes       Date:  2021-06-09       Impact factor: 3.168

9.  Impact of the Dynamic Change of Metabolic Health Status on the Incident Type 2 Diabetes: A Nationwide Population-Based Cohort Study.

Authors:  Jung A Kim; Da Hye Kim; Seon Mee Kim; Yong Gyu Park; Nan Hee Kim; Sei Hyun Baik; Kyung Mook Choi; Kyungdo Han; Hye Jin Yoo
Journal:  Endocrinol Metab (Seoul)       Date:  2019-12

10.  Metabolically healthy obesity, transition to unhealthy phenotypes, and type 2 diabetes in 0.5 million Chinese adults: the China Kadoorie Biobank.

Authors:  Zimin Song; Meng Gao; Jun Lv; Canqing Yu; Yu Guo; Zheng Bian; Yuxia Wei; Ling Yang; Huaidong Du; Yiping Chen; Jianqiang Zhang; Jvying Yao; Junshi Chen; Zhengming Chen; Tao Huang; Liming Li
Journal:  Eur J Endocrinol       Date:  2022-01-06       Impact factor: 6.558

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.